JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

2023/11/05 by Marco Fischer, Peter Olbrich, Jérôme Hadjadj +70 · 3 citations
Immunology and Microbiology · Medicine · #Autoimmune and Inflammatory Disorders Research #Immunodeficiency and Autoimmune Disorders #Mycobacterium research and diagnosis

paper · pdf · doi:10.1016/j.jaci.2023.10.018

openalex publication_date 2023/11/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
• Clinical and Immunological Impact of JAK Inhibition in Concurrent Down Syndrome and STAT1 Gain of Function
• Hematopoietic cell transplantation in inborn errors of immunity - Part II: others